Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
32051 | 144 | 33.2 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
668 | 3 | ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIN RECEPTORS | 9913 |
1078 | 2 | ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIN RECEPTORS | 9913 |
32051 | 1 | CD10//CD10 EXPRESSION//BIOPATHOLUMR 599 | 144 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CD10 | authKW | 1722954 | 40% | 14% | 58 |
2 | CD10 EXPRESSION | authKW | 381692 | 2% | 60% | 3 |
3 | BIOPATHOLUMR 599 | address | 212052 | 1% | 100% | 1 |
4 | CD 10 EXPRESSION | authKW | 212052 | 1% | 100% | 1 |
5 | CD10 ENZYME | authKW | 212052 | 1% | 100% | 1 |
6 | CD10 NEGATIVE OR VERY WEAKLY POSITIVE STAINING | authKW | 212052 | 1% | 100% | 1 |
7 | CD10 STRONGLY POSITIVE STAINING | authKW | 212052 | 1% | 100% | 1 |
8 | CD10WEAKLY POSITIVE STAINING | authKW | 212052 | 1% | 100% | 1 |
9 | CRLCC CAL AURELLE RECH CANCEROL | address | 212052 | 1% | 100% | 1 |
10 | DEPTH OF INVASION CLARK | authKW | 212052 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pathology | 1597 | 30% | 0% | 43 |
2 | Oncology | 676 | 36% | 0% | 52 |
3 | Anatomy & Morphology | 52 | 3% | 0% | 4 |
4 | Dermatology | 48 | 5% | 0% | 7 |
5 | Cell Biology | 47 | 11% | 0% | 16 |
6 | Urology & Nephrology | 40 | 6% | 0% | 8 |
7 | Medicine, Research & Experimental | 35 | 7% | 0% | 10 |
8 | Cell & Tissue Engineering | 28 | 1% | 0% | 2 |
9 | Gastroenterology & Hepatology | 26 | 5% | 0% | 7 |
10 | Medical Laboratory Technology | 18 | 2% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPATHOLUMR 599 | 212052 | 1% | 100% | 1 |
2 | CRLCC CAL AURELLE RECH CANCEROL | 212052 | 1% | 100% | 1 |
3 | MED JOAN STANFORD 1 | 212052 | 1% | 100% | 1 |
4 | MED ONCOLUMR599 | 212052 | 1% | 100% | 1 |
5 | MOL ONCOLUMR599 | 212052 | 1% | 100% | 1 |
6 | SERV CITOMETRIA CBA | 212052 | 1% | 100% | 1 |
7 | SURG SUBSPECIALTIES COLON RECTAL SURG | 212052 | 1% | 100% | 1 |
8 | UROL JOAN STANFORD 1 | 212052 | 1% | 100% | 1 |
9 | JOAN STANFORD I WEILL MED | 119275 | 2% | 19% | 3 |
10 | GENITOUINARY MED ONCOL | 106025 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VIRCHOWS ARCHIV | 1602 | 3% | 0% | 5 |
2 | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 1281 | 2% | 0% | 3 |
3 | CANCER CELL INTERNATIONAL | 1103 | 1% | 0% | 2 |
4 | ANNALI ITALIANI DI CHIRURGIA | 1008 | 1% | 0% | 2 |
5 | ONCOGENESIS | 804 | 1% | 0% | 1 |
6 | PATHOBIOLOGY | 774 | 1% | 0% | 2 |
7 | CLINICAL CANCER RESEARCH | 692 | 5% | 0% | 7 |
8 | HISTOPATHOLOGY | 604 | 3% | 0% | 4 |
9 | CANCER SCIENCE | 537 | 2% | 0% | 3 |
10 | ORAL DISEASES | 525 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD10 | 1722954 | 40% | 14% | 58 | Search CD10 | Search CD10 |
2 | CD10 EXPRESSION | 381692 | 2% | 60% | 3 | Search CD10+EXPRESSION | Search CD10+EXPRESSION |
3 | CD 10 EXPRESSION | 212052 | 1% | 100% | 1 | Search CD+10+EXPRESSION | Search CD+10+EXPRESSION |
4 | CD10 ENZYME | 212052 | 1% | 100% | 1 | Search CD10+ENZYME | Search CD10+ENZYME |
5 | CD10 NEGATIVE OR VERY WEAKLY POSITIVE STAINING | 212052 | 1% | 100% | 1 | Search CD10+NEGATIVE+OR+VERY+WEAKLY+POSITIVE+STAINING | Search CD10+NEGATIVE+OR+VERY+WEAKLY+POSITIVE+STAINING |
6 | CD10 STRONGLY POSITIVE STAINING | 212052 | 1% | 100% | 1 | Search CD10+STRONGLY+POSITIVE+STAINING | Search CD10+STRONGLY+POSITIVE+STAINING |
7 | CD10WEAKLY POSITIVE STAINING | 212052 | 1% | 100% | 1 | Search CD10WEAKLY+POSITIVE+STAINING | Search CD10WEAKLY+POSITIVE+STAINING |
8 | DEPTH OF INVASION CLARK | 212052 | 1% | 100% | 1 | Search DEPTH+OF+INVASION+CLARK | Search DEPTH+OF+INVASION+CLARK |
9 | IMMUNOHISTOCHEMISHY | 212052 | 1% | 100% | 1 | Search IMMUNOHISTOCHEMISHY | Search IMMUNOHISTOCHEMISHY |
10 | MUC5AC EXPRESSION | 212052 | 1% | 100% | 1 | Search MUC5AC+EXPRESSION | Search MUC5AC+EXPRESSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GUREL, D , KARGI, A , KARAMAN, I , ONEN, A , UNLU, M , (2012) CD10 EXPRESSION IN EPITHELIAL AND STROMAL CELLS OF NON-SMALL CELL LUNG CARCINOMA (NSCLC): A CLINIC AND PATHOLOGIC CORRELATION.PATHOLOGY & ONCOLOGY RESEARCH. VOL. 18. ISSUE 2. P. 153-160 | 22 | 63% | 8 |
2 | OBA, J , NAKAHARA, T , HAYASHIDA, S , KIDO, M , XIE, LN , TAKAHARA, M , UCHI, H , MIYAZAKI, S , ABE, T , HAGIHARA, A , ET AL (2011) EXPRESSION OF CD10 PREDICTS TUMOR PROGRESSION AND UNFAVORABLE PROGNOSIS IN MALIGNANT MELANOMA.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 65. ISSUE 6. P. 1152 -1160 | 22 | 48% | 8 |
3 | MAGUER-SATTA, V , BESANCON, R , BACHELARD-CASCALES, E , (2011) CONCISE REVIEW: NEUTRAL ENDOPEPTIDASE (CD10): A MULTIFACETED ENVIRONMENT ACTOR IN STEM CELLS, PHYSIOLOGICAL MECHANISMS, AND CANCER.STEM CELLS. VOL. 29. ISSUE 3. P. 389 -396 | 25 | 35% | 48 |
4 | FUJITA, S , YAMAMOTO, S , AKASU, T , MORIYA, Y , TANIGUCHI, H , SHIMODA, T , (2007) QUANTIFICATION OF CD10 MRNA IN COLORECTAL CANCER AND RELATIONSHIP BETWEEN MRNA EXPRESSION AND LIVER METASTASIS.ANTICANCER RESEARCH. VOL. 27. ISSUE 5A. P. 3307 -3311 | 16 | 64% | 9 |
5 | HASHIMOTO-HACHIYA, A , OBA, J , NAKAHARA, T , LIU, M , ABE, T , HAGIHARA, A , YOKOMIZO, T , FURUE, M , (2016) CD10-EQUIPPED MELANOMA CELLS ACQUIRE HIGHLY POTENT TUMORIGENIC ACTIVITY: A PLAUSIBLE EXPLANATION OF THEIR SIGNIFICANCE FOR A POOR PROGNOSIS.PLOS ONE. VOL. 11. ISSUE 2. P. - | 17 | 41% | 1 |
6 | DESCHAMPS, L , HANDRA-LUCA, A , O'TOOLE, D , SAUVANET, A , RUSZNIEWSKI, P , BELGHITI, J , BEDOSSA, P , COUVELARD, A , (2006) CD10 EXPRESSION IN PANCREATIC ENDOCRINE TUMORS: CORRELATION WITH PROGNOSTIC FACTORS AND SURVIVAL.HUMAN PATHOLOGY. VOL. 37. ISSUE 7. P. 802 -808 | 12 | 71% | 32 |
7 | BERNESCU, I , REICHSTEIN, AC , LUCHTEFELD, M , OGILVIE, JW , (2016) DOES CD10 EXPRESSION PREDICT LYMPH NODE METASTASIS IN COLORECTAL CANCER?.DISEASES OF THE COLON & RECTUM. VOL. 59. ISSUE 1. P. 22 -27 | 10 | 63% | 1 |
8 | JANG, TJ , (2012) CD10 IS AGAIN EXPRESSED AT A CERTAIN STAGE DURING THE NEOPLASTIC PROCESS OF BLADDER TRANSITIONAL CELL CARCINOMAS.CANCER RESEARCH AND TREATMENT. VOL. 44. ISSUE 4. P. 262-266 | 13 | 57% | 1 |
9 | OMRAN, OM , (2012) CD10 AND E-CAD EXPRESSION IN URINARY BLADDER UROTHELIAL AND SQUAMOUS CELL CARCINOMA.JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY. VOL. 31. ISSUE 3. P. 203-212 | 16 | 41% | 8 |
10 | ATIQUE, M , ABBASI, MS , JAMAL, S , KHADIM, MT , AKHTAR, F , JAMAL, N , (2014) CD 10 EXPRESSION INTENSITY IN VARIOUS GRADES AND STAGES OF UROTHELIAL CARCINOMA OF URINARY BLADDERE.JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN. VOL. 24. ISSUE 5. P. 351-355 | 10 | 63% | 1 |
Classes with closest relation at Level 1 |